Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Francesca Sozio

Showing results (11-20 of 27) with videos related to

Pageof 3
Sort By:
International Journal of Molecular Sciences|June 4, 2020
Functional Role of Dendritic Cell Subsets in Cancer Progression and Clinical ImplicationsAnnalisa Del Prete, Francesca Sozio, Ilaria Barbazza, et al.
Journal of Leukocyte Biology|September 4, 2024
Chemerin in immunityMattia Laffranchi, Tiziana Schioppa, Francesca Sozio, et al.
Cancer Immunology Research|September 6, 2019
The Atypical Receptor CCRL2 Is Essential for Lung Cancer Immune SurveillanceAnnalisa Del Prete, Francesca Sozio, Tiziana Schioppa, et al.
Frontiers in Immunology|February 10, 2022
The PDE4 Inhibitor Tanimilast Blunts Proinflammatory Dendritic Cell Activation by SARS-CoV-2 ssRNAsHoang Oanh Nguyen, Tiziana Schioppa, Laura Tiberio, et al.
Journal of Translational Medicine|May 10, 2022
The PDE4 inhibitor tanimilast shows distinct immunomodulatory properties associated with a type 2 endotype and CD141 upregulationHoang Oanh Nguyen, Valentina Salvi, Laura Tiberio, et al.
European Journal of Immunology|September 22, 2025
TNF Production or TNFR2 Expression Characterize Distinct States of Regulatory T Cells that Cooperate in Treg Expansion in Cancer and Chronic InflammationGloria Tucci, Ilenia Pacella, Alessandra Pinzon Grimaldos, et al.
Oncoimmunology|May 16, 2026
An orthotopic organoid-based model to study early CD8⁺ T cell dysfunction and immunotherapy response in colorectal cancerLorenzo Lucantonio, Ludovica Schiano, Francesca Sozio, et al.
International Journal of Molecular Sciences|May 14, 2022
The PDE4 Inhibitor Tanimilast Restrains the Tissue-Damaging Properties of Human NeutrophilsTiziana Schioppa, Hoang Oanh Nguyen, Valentina Salvi, et al.
Blood|July 27, 2017
The atypical receptor CCRL2 is required for CXCR2-dependent neutrophil recruitment and tissue damageAnnalisa Del Prete, Laura Martínez-Muñoz, Cristina Mazzon, et al.
JCI Insight|August 10, 2021
SARS-CoV-2-associated ssRNAs activate inflammation and immunity via TLR7/8Valentina Salvi, Hoang Oanh Nguyen, Francesca Sozio, et al.
Pageof 3

Showing results (11-20 of 27) with videos related to

Sort By:
Pageof 3
International Journal of Molecular Sciences|June 4, 2020
Functional Role of Dendritic Cell Subsets in Cancer Progression and Clinical ImplicationsAnnalisa Del Prete, Francesca Sozio, Ilaria Barbazza, et al.
Journal of Leukocyte Biology|September 4, 2024
Chemerin in immunityMattia Laffranchi, Tiziana Schioppa, Francesca Sozio, et al.
Cancer Immunology Research|September 6, 2019
The Atypical Receptor CCRL2 Is Essential for Lung Cancer Immune SurveillanceAnnalisa Del Prete, Francesca Sozio, Tiziana Schioppa, et al.
Frontiers in Immunology|February 10, 2022
The PDE4 Inhibitor Tanimilast Blunts Proinflammatory Dendritic Cell Activation by SARS-CoV-2 ssRNAsHoang Oanh Nguyen, Tiziana Schioppa, Laura Tiberio, et al.
Journal of Translational Medicine|May 10, 2022
The PDE4 inhibitor tanimilast shows distinct immunomodulatory properties associated with a type 2 endotype and CD141 upregulationHoang Oanh Nguyen, Valentina Salvi, Laura Tiberio, et al.
European Journal of Immunology|September 22, 2025
TNF Production or TNFR2 Expression Characterize Distinct States of Regulatory T Cells that Cooperate in Treg Expansion in Cancer and Chronic InflammationGloria Tucci, Ilenia Pacella, Alessandra Pinzon Grimaldos, et al.
Oncoimmunology|May 16, 2026
An orthotopic organoid-based model to study early CD8⁺ T cell dysfunction and immunotherapy response in colorectal cancerLorenzo Lucantonio, Ludovica Schiano, Francesca Sozio, et al.
International Journal of Molecular Sciences|May 14, 2022
The PDE4 Inhibitor Tanimilast Restrains the Tissue-Damaging Properties of Human NeutrophilsTiziana Schioppa, Hoang Oanh Nguyen, Valentina Salvi, et al.
Blood|July 27, 2017
The atypical receptor CCRL2 is required for CXCR2-dependent neutrophil recruitment and tissue damageAnnalisa Del Prete, Laura Martínez-Muñoz, Cristina Mazzon, et al.
JCI Insight|August 10, 2021
SARS-CoV-2-associated ssRNAs activate inflammation and immunity via TLR7/8Valentina Salvi, Hoang Oanh Nguyen, Francesca Sozio, et al.
Pageof 3